Theriva Biologics, Inc. Loans Payable
Theriva Biologics, Inc. (TOVX) had Loans Payable of $1.65 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LoansPayable · last filed 2026-08-11
- 2026-06-30: Loans Payable $1.65M.
- 2026-03-31: Loans Payable $1.66M.
- 2025-12-31: Loans Payable $1.73M.
- 2025-09-30: Loans Payable $1.71M.
| Period end | Loans Payable |
|---|---|
| 2026-06-30 | $1.65M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.73M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.71M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |